Summary
Overview
Work History
Education
Skills
Accomplishments
Certification
Awards
Email
Great Catch Aware from Yale New Haven Hospital
Languages
Timeline
Generic
KRISTIN CURRAN

KRISTIN CURRAN

Hamden

Summary

I am a licensed physician assistant with 15 years of practice experience. I have spent 3 years practicing in the field of Rheumatology, Allergy and Immunology, 9 years practicing in Pulmonary and Critical Care Medicine and 3 years in the field of Internal Medicine.

Overview

21
21
years of professional experience
1
1
Certification

Work History

Physician Assistant - Rheumatology

Yale New Haven Hospital
06.2022 - Current
  • Provides clinical care including routine follow up and urgent visits to patients with Rheumatic Diseases (rheumatoid arthritis, lupus, psoriatic arthritis, gout, ankylosing spondylitis, polymyositis, dermatomyositis, antisynthetase syndrome, Sjogrens, polymyalgia rheumatica, giant cell arteritis, generalized osteoarthritis, mixed connective tissue disease, undifferentiated connective tissue disease)
  • Performs preoperative examination is and makes recommendations regarding perioperative management of immunosuppressive medication
  • Coordinates care with subspecialty providers
  • Coordinates care with inpatient team during hospital admissions as needed
  • Lead COVID-19 treatment provider for site offering high risk immunosuppressed patients treatment, counseling and guidance on the evaluation and management of COVID-19 in immunosuppressed states
  • Performs injections (knee, subacromial bursa and trochanteric bursa injections)
  • Places outside referrals, physical therapy orders
  • Triages and manages patient calls, MyChart e-mails and medication refills for site
  • Oversees nursing injections visits
  • Orders infusion therapy plans
  • Orders and interprets blood work and diagnostic tests (MRI, CT scan, x-ray)
  • FMLA and disability paperwork

Physician Assistant

Yale New Haven Hospital
08.2012 - 06.2022
  • Provides clinical care including urgent and same day visits, routine follow ups, hospital follow ups, preoperative clearances
  • Daily program coverage for 6 physicians and cross coverage of pulmonary subspecialty programs including triage and management of high volume of patient calls, MyChart E-mails, prescription refills, DME orders, medication and imaging prior authorizations, pulmonary rehab referrals
  • Ordering/interpreting diagnostic testing and imaging and executing treatment plan (pulmonary function tests, high resolution chest CT, chest x-rays, echocardiograms, stress tests, EKGs, Holter
  • Completing daily progress notes closing encounters within 24 hours
  • Coordinates patient care with other tertiary care centers including lung transplant programs
  • Coordinates hospital admissions and communicates with ED and inpatient team as needed
  • Applies for financial assistance (applies for grants for compassionate use, co-pay assistance) for specialty medications through drug manufacturer and foundations
  • Training and onboarding of PA students
  • training and onboarding of nursing and administrative staff as needed to meet program needs
  • New referral coordinator (tracking of referrals, record retrieval, imaging uploading and database maintenance)
  • Creation of patient education resources and EPIC smart phrases for the program
  • Patient support group leader through Scleroderma Foundation
  • Patient support group leader through Pulmonary Fibrosis Foundation
  • Subinvestigator on clinical trials as below:
  • Protocol Title: PGCL-3019-067, A Phase 2,
    Randomized, Double Blind, Placebo ControlledStudy
    to Evaluate the Safety and Efficacy of FG-3019 in
    Patients with Idiopathic Pulmonary Fibrosis.
    Protocol Number FGCL-3019-067 (Fibrogen, Inc).
    HIC# 1303011684.
  • Protocol Title: PIPF031, A Treatment Protocol to
    Allow Patients in the US with Idiopathic Pulmonary
    Fibrosis Access to Pirfenidone. Protocol Number
    PIPF031. HIC# 1406014085
  • Genentech Roche: Protocol #GB28547- Protocol Title:
    A Phase II, Randomized, Double-Blind, Placebo-
    Controlled, Study to Assess the Efficacy and Safety of
    Lebrikizumab in Patients with Idiopathic Pulmonary
    Fibrosis. HIC# 1308012528
  • Protocol Title: An Open Label Extension Study of the
    Long Term Safety of Pirfenidone in Patients with
    Idiopathic Pulmonary Fibrosis. Protocol Number:
    PIPF-012. HIC# 0804003712.
    Protocol Title: Prednisone, Azathioprine, and Nacetylcystine:
    A Study That Evaluates Response in
    Idiopathic Pulmonary Fibrosis. Clinical Trials.Gov
    Number NCT00650091.
  • Protocol Title: Safety and Efficacy of a
    Lysophosphatidic Acid Receptor Antagonist in
    Idiopathic Pulmonary Fibrosis Safety and Efficacy of
    a Lysophosphatidic Acid Receptor Antagonist in
    Idiopathic Pulmonary Fibrosis. A Multicenter,
    Randomized, Double-Blind, Placebo-Controlled,
    Phase 2 Study of the Safety and Efficacy of BMS-
    986020 in Subjects with Idiopathic Pulmonary
    Fibrosis. HIC# 1308012484
  • Protocol Title: Promedior HIC#1508016352 - A Phase
    2 Trial to Evaluate the Efficacy of PRM-151 in
    Subjects with Idiopathic Pulmonary Fibrosis. PRM-
    151-202/Pentraxin-2 (Promedior, INC)
    Boehringer-Ingelheim; HIC#1511016843.
  • Protocol Title: BI 1199.214, A double blind, randomized,
    placebo-controlled trial evaluating efficacy and
    safety of oral Nintedanib treatment for at least 52
    weeks in patients with ‘Systemic Sclerosis associated
    Interstitial Lung Disease'(SSc-ILD) (Boehringer
    Inglelheim) A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nintedanib over
    52 weeks in patients with Progressive Fibrosing
    Interstitial Lung Disease (PF-ILD), HIC #2000021368
  • Boehringer 1199.225 “An Open-Label Extension Trial
    to Assess the Long-Term Safety of nintedanib in
    Patients with ‘Systemic Sclerosis Associated
    Interstitial Lung Disease' (SSc-ILD)” HIC #
    2000023096. A Follow-up study investigating long term treatment with nintedanib in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD), HIC #2000025055·
  • Biogen 203PF203 “A Randomized, Double-Blind,
    Placebo-Controlled Study to Evaluate the Efficacy and
    Safety of BG00011 in Patients with Idiopathic Pulmonary
    Fibrosis (IPF)”HIC # 2000024800
  • Galacteco Biotech. A randomized, double-blind,
    multicenter, parallel, placebo-controlled Phase 2b study
    in subjects with idiopathic pulmonary fibrosis (IPF)
    investigating the efficacy and safety of TD139, an inhaled
    galectin-3 inhibitor administered via a dry powder
    inhaler over 52 weeks - GALACTIC-1
  • Galapagos. GLPG1609-CL-3-3: Phase3 randomized
    double-blindparallel group placebo controlled multicenter
    study to evaluate the efficacy and safety of 2
    doses of GLPG1690 in addition to local standard of care
    for minimum 52 weeks in subjects with idiopathic
    pulmonary fibrosis, HIC #2000025140
    GLPG1690 is a novel post selective small molecule
    inhibitor about attacks in. Also known as econucleotide
    pyrophosphatase/phosphodiesterase 2 (ENPP2) or
    lysopholipase D (LPD). Responsible for hydrolysis of LPC
    to produce LPA.·
  • Participation in translational research: Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis, (GRADS). HIC# 1303011714 (Alpha 1), HIC# 1303011721 (Sarcoidosis)· Translational
    Studies of Skin and Lung Involvement in Scleroderma,
    Idiopathic Pulmonary Fibrosis (IPF) and Pulmonary
    Artery Hypertension (PAH), (BIOGEN). HIC# 1309012734·
    Idiopathic Pulmonary Fibrosis Prospective Outcomes
    (IPF-PRO) RegistryBoehringer Ingelheim "Idiopathic
    Pulmonary Fibrosis Prospective Outcomes (IPF-PRO)
    Registry” HIC # 1406014086 4. The Yale Lung Repository
    (TYLR) – this is the section-wide department repository.
    HIC# 1307012431.· PFF. HIC# 1604017642.

Physician Assistant - Internal Medicine

Broadway Medical Group
01.2010 - 08.2012
  • Patient education and counseling
  • Management of chronic disease including asthma, COPD, ABPA, CHF, diabetes, cirrhosis, hypertension, hypercholesterolemia, atrial fibrillation, thyroid disorders, osteoporosis, CKD, OAB, BPH, psoriasis, anxiety/depression, celiac disease, gout, anemia, PMR, fibromyalgia, OA, chronic back pain, testosterone deficiency, suboxone, PAD, CAD, OSA, endocarditis, etc
  • Acute care visits for conditions including empyema, amaurosis fugax, asthma/COPD exacerbations, pneumonia, bronchitis, IBS/IBD, gallbladder disease, syncope, pancreatitis, nephrolithiasis, pyelonephritis, tick borne illnesses, pleural effusion, PE, DVT, phlebitis, GI bleed, hemorrhoids, tinnitus, vertigo, sialadenitis, cellulitis, RTC injuries, meniscal tears, dysphagia, GER, viral illnesses including influenza, giardia, cellulitis, lacerations, MRSA, HZV/HSV, AOM, serous otitis, sinusitis, tonsillitis, nose bleeds, migraine, CVA, alcohol detoxification, cervical/lumbar radiculopathy, malaria prophylaxis, STD's, HPV education, diverticular disease
  • Injections including Testosterone, Procrit, Ovidrel, vitamin B12, flu, Pneumovax, HBV vaccinations, Xolair, MMR, Menactra, Gardasil, Boniva
  • Reviewing of holter reports, stress tests, echocardiograms, EKG and spirometry
  • Procedures including knee injections, incision and drainage, suturing, draining of joint effusions, cerumen impaction removal, foreign body removal from ear/eye, fluorescein staining, tonometry

Pharmacy Technician

Rite Aid
05.2006 - 07.2007

Personal Home Health Care Aide

05.2005 - 05.2006

PT Aide

05.2005 - 05.2006

Oral Surgery Assistant

Stoler, Capuano & Schwartz Oral Surgery
05.2004 - 08.2004

Education

MASTERS OF HEALTH SCIENCE -

Quinnipiac University
Hamden, CT
01.2009

BACHELOR OF HEALTH SCIENCE -

Quinnipiac University
Hamden, CT
01.2007

Comsewogue High School -

Comsewogue High School
Port Jefferson Station, NY

Skills

  • Ability to perform high volume, efficient and coordinated clinical care
  • Interest in leadership initiatives and program development
  • Flexibility to changing job roles and descriptions
  • Interest in establishing long term commitment to position

Accomplishments

Promoted to APP level 2 at Yale New Haven Hospital

Certification

  • Physician Assistant Certified, 2009-01-01, current
  • NCCPA Board Certified, 2009-01-01, current
  • CT state license, 2009-01-01, current
  • DEA license, 2009-01-01, current
  • CT controlled substance license, 2009-01-01, current
  • ACLS, 2008-01-01, current
  • BLS/CPR certified, 2008-01-01, current
  • EMT-B, 2005-01-01, 2011-01-01

Awards

  • Magna Cum Laude, 2009
  • Dean's List, 2003-2007
  • US Lacrosse All American, 2003

Email

Kristin.Curran@Yale.edu, kdpapu@gmail.com

Great Catch Aware from Yale New Haven Hospital

Project focused on developing a program to offer patients with immunosuppress state increased access to care and treatment for COVID-19, vaccine counseling and immunosuppression guidance

Languages

English
Native or Bilingual
Spanish
Limited Working

Timeline

Physician Assistant - Rheumatology

Yale New Haven Hospital
06.2022 - Current

Physician Assistant

Yale New Haven Hospital
08.2012 - 06.2022

Physician Assistant - Internal Medicine

Broadway Medical Group
01.2010 - 08.2012

Pharmacy Technician

Rite Aid
05.2006 - 07.2007

Personal Home Health Care Aide

05.2005 - 05.2006

PT Aide

05.2005 - 05.2006

Oral Surgery Assistant

Stoler, Capuano & Schwartz Oral Surgery
05.2004 - 08.2004

BACHELOR OF HEALTH SCIENCE -

Quinnipiac University

Comsewogue High School -

Comsewogue High School

MASTERS OF HEALTH SCIENCE -

Quinnipiac University

Similar Profiles

CREATE PROFILE
KRISTIN CURRAN